Developer docs
API playgroundTry for free, no card

Search company profiles

AniCell Biotech

Full company profile

uuid000gpan

Namestring
AniCell Biotech
Legal namestring
AniCell Biotech, LLC
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChandler, United States
HQ citystring
Chandler
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regenerative veterinary products, amnion-derived bioscaffolds, equine regenerative medicine, canine wound care, veterinary orthobiologics
Industry4 codes
PRIMARYHLAMANAK
Point-of-Care Regenerative Kits & Devices (Processing/Delivery)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAG
Wound Healing & Dermatologic Regeneration
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAA
Stem Cell Therapies (Autologous & Allogeneic)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Veterinary Regenerative Medicine
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Veterinary Product Sales
TypeOne Time License
Description

AniCell sells its regenerative amnion-derived products directly to veterinarians who administer treatments to animals. Products include StemWrap, AniMatrX, AniMotion, AniOcular and related product lines for equine and canine applications. Veterinarians order through the Vet Access portal or via sales representatives.

anicellbiotech.com
2Distribution Partnership Revenue
TypeOne Time License
Description

Products distributed through MWI Animal Health distributor network, generating revenue through wholesale distribution channels to veterinary practices across the United States.

anicellbiotech.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D
Pricing details2 tiers
1Stem cell therapy for dogs
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Treatment costs between $2,500 and $3,000 for canine stem cell therapy using amnion-derived products, as reported for Dr. Richman's clinic. Some pet insurance plans cover this treatment.

anicellbiotech.com
2Quantity discounts available
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quantity pricing for AniCell products offers up to 22% discount for bulk purchases.

anicellbiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1EquusCell
Description

Product line for horses focusing on regenerative treatment for tendons, ligaments, joints, and superficial wounds

anicellbiotech.com
+7 more records
Core offering1 text field

AniCell Biotech develops and manufactures ready-to-use, all-natural regenerative bioscaffold products derived from equine amniotic material for veterinary use. The portfolio includes two main brands—EquusCell for horses and CanisCell for dogs—with membrane bandages (StemWrap), injectable allografts (AniMatrX, AniMotion), ophthalmic products (AlloOcular, AniOcular), and temperature-independent formulations (AniCell D line). Products support wound management, tendon and ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Horses resumed activities in half the time compared to conventional treatments
+4 more records
Product overview1 text field

AniCell Biotech offers regenerative veterinary products derived from equine amniotic material collected non-invasively during parturition. The product portfolio consists of two main brands: EquusCell for horses and CanisCell for dogs. Key products include StemWrap/StemWrap Plus (membrane bandages), AniMatrX/AniMotion (injectable allografts), and AlloOcular (ophthalmic products). Products provide all-natural, minimally manipulated regenerative solutions for wound healing, tendon/ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.

Product and service13 records
1EquusCell
CategoryRegenerative veterinary products - Equine
2CanisCell
CategoryRegenerative veterinary products - Canine
3StemWrap
CategoryWound management membrane
4StemWrap Plus
CategoryWound management membrane
5StemWrap D
CategoryWound management membrane
6AniMatrX
CategoryInjectable regenerative allograft
7AniMatrX-D
CategoryInjectable regenerative allograft
8AniMotion
CategoryInjectable regenerative allograft
9AlloOcular
CategoryOphthalmic regenerative product
10AniOcular
CategoryOphthalmic regenerative product
11AlloMatrix
CategoryRegenerative allograft
12EquusCell D
CategoryRegenerative veterinary products - Equine
13CanisCell StemWrap
CategoryWound management membrane
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

MWI Animal Health is AniCell's primary distribution partner for veterinary products across the United States. The website displays 'Proud to be distributed by MWI' indicating a formal distribution agreement.

2American Association of Equine Practitioners (AAEP)
Strategic tierCoreTypeGTM or Marketing Partner
Description

AniCell is a corporate sponsor of AAEP and presents at annual conferences. Hosts AAEP Conference Registration for CE courses. Company has presented at AAEP events for multiple years.

anicellbiotech.com
3North American Veterinary Community (VMX Conference)
Strategic tierMajorTypeGTM or Marketing Partner
Description

Exhibits at VMX Conference (Booth 2649) annually, showcasing products to veterinary professionals from around the world.

anicellbiotech.com
4Western Veterinary Conference (WVC)
Strategic tierMajorTypeGTM or Marketing Partner
Description

Exhibits at WVC Vegas Conference (Booth 3961) annually with presence in February.

anicellbiotech.com
5Lake Tahoe Equine Conference
Strategic tierMajorTypeGTM or Marketing Partner
Description

Participates in the Forty-Seventh Annual Lake Tahoe Equine Conference (January 26-30, 2026) as an exhibitor and educational supporter.

anicellbiotech.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Corporate sponsor of Texas Equine Veterinary Association Foundation events and silent auctions supporting veterinarians in need.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Corporate sponsor of ISELP (International Society of Equine Professionals). Company logo appears alongside 'Proud to be corporate sponsors of ISELP'.

8Dr. Marty Goldstein
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Dr. Marty Goldstein DVM who lectures on integrative veterinary approaches to promote longevity and wellness through regenerative technologies. Company provides support for his educational presentations.

anicellbiotech.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Lauren Schnabel at NC State University conducts clinical research on AniCell products including StemWrap wound healing studies. Her lab published peer-reviewed research supporting product efficacy.

10Dr. Moises Barcelo (Dr. Moises Barcelo-Fimbres)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bioprocess engineer and research veterinarian Dr. Moises Barcelo has developed multiple product lines including EquusCell, CanisCell, and temperature-independent products. Key inventor and technical advisor.

anicellbiotech.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Vetoquinol is a global animal-health pharma with equine and companion animal therapeutics (including regenerative/orthopedic adjacencies); another broad incumbent that competes for shelf space and CE audiences at AAEP/VMX/WVC where AniCell also markets.

TypeBroad incumbent
Description

Heska, now part of Mars Petcare, sells in-clinic diagnostics and therapeutic products to companion-animal practices; overlaps in the same vet-channel buyer as AniCell and could potentially house or bundle regenerative SKUs at scale.

3Ardent Animal Health
TypeDirect peer
Description

Ardent Animal Health (parent of MediVet Biologics) provides platelet-rich plasma and regenerative therapies for companion animals and horses, directly overlapping AniCell's regenerative product positioning in vet clinics.

TypeBroad incumbent
Description

Zoetis is the largest global animal-health company with equine and companion animal portfolios including regenerative and biologic adjacencies (e.g., cytology, PRP, orthobiologics), serving as the dominant broad incumbent AniCell could be acquired by or compete against.

TypeBroad incumbent
Description

Dechra is a specialty animal-health pharma with strong equine (Equistro, orthopedic) and small-animal therapeutic lines; an active acquirer of niche regenerative/biologic franchises and a logical strategic acquirer of a platform like AniCell.

TypeBroad incumbent
Description

Elanco Animal Health is a major broad-line animal-health company with companion-animal and equine product portfolios, providing scale distribution and R&D resources against which AniCell's niche regenerative offerings must compete for clinic mind-share.

7VetStem Biopharma
TypeDirect peer
Description

VetStem Biopharma is a regenerative medicine company offering autologous stem cell therapy services for dogs and horses, the closest functional analogue to AniCell's amnion-derived allograft products and the typical alternative veterinarians compare against.

TypeEmerging player
Description

PetVivo commercializes veterinary medical devices (e.g., Kushion and PrecisePRP) targeting osteoarthritis and tendon/ligament injuries in dogs and horses, competing in overlapping equine/canine regenerative and orthopedic indications.

TypeDirect peer
Description

MediVet Biologics, now part of Ardent Animal Health, sells in-clinic regenerative kits (e.g., in-clinic stem cell kits) used by equine and small animal vets; comparable distribution motion (vet channel) and competitive substitute to AniCell's allograft approach.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Boehringer Ingelheim Animal Health is a top-tier global animal-health company with equine, livestock, and pet therapeutics; its broad regenerative/biologic R&D budget dwarfs AniCell's and frames the competitive ceiling in advanced veterinary therapeutics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AniCell Biotech

Veterinary Regenerative Medicineanicellbiotech.com

AniCell Biotech firmographics

Firmographics
Name
AniCell Biotech
Legal name
AniCell Biotech, LLC
Website
https://anicellbiotech.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

AniCell Biotech industry classification

Industry
Product category
Veterinary Regenerative Medicine
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMANAK
Point-of-Care Regenerative Kits & Devices (Processing/Delivery)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAG
Wound Healing & Dermatologic Regeneration
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAA
Stem Cell Therapies (Autologous & Allogeneic)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Regenerative veterinary products
  • Amnion-derived bioscaffolds
  • Equine regenerative medicine
  • Canine wound care
  • Veterinary orthobiologics

Where AniCell Biotech is headquartered

Location

Headquarters

HQ city
Chandler
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AniCell Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Veterinary Product Sales: AniCell sells its regenerative amnion-derived products directly to veterinarians who administer treatments to animals. Products include StemWrap, AniMatrX, AniMotion, AniOcular and related product lines for equine and canine applications. Veterinarians order through the Vet Access portal or via sales representatives.
  2. Distribution Partnership Revenue: Products distributed through MWI Animal Health distributor network, generating revenue through wholesale distribution channels to veterinary practices across the United States.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goStem cell therapy for dogs
Unit PricingPay-as-you-goQuantity discounts available

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

AniCell Biotech product offering

Product offering

Core offering

AniCell Biotech develops and manufactures ready-to-use, all-natural regenerative bioscaffold products derived from equine amniotic material for veterinary use. The portfolio includes two main brands—EquusCell for horses and CanisCell for dogs—with membrane bandages (StemWrap), injectable allografts (AniMatrX, AniMotion), ophthalmic products (AlloOcular, AniOcular), and temperature-independent formulations (AniCell D line). Products support wound management, tendon and ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.

Product overview

AniCell Biotech offers regenerative veterinary products derived from equine amniotic material collected non-invasively during parturition. The product portfolio consists of two main brands: EquusCell for horses and CanisCell for dogs. Key products include StemWrap/StemWrap Plus (membrane bandages), AniMatrX/AniMotion (injectable allografts), and AlloOcular (ophthalmic products). Products provide all-natural, minimally manipulated regenerative solutions for wound healing, tendon/ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.

Differentiator

Problem solved

Functional benefit

Brands

  • EquusCell: Product line for horses focusing on regenerative treatment for tendons, ligaments, joints, and superficial wounds
  • CanisCell
  • AlloMatrix
  • AlloMotion
  • AlloOcular
  • StemWrap
  • AniMotion
  • AniMatrX

Products and services

  • EquusCell
  • CanisCell
  • StemWrap
  • StemWrap Plus
  • StemWrap D
  • AniMatrX
  • AniMatrX-D
  • AniMotion
  • AlloOcular
  • AniOcular
  • AlloMatrix
  • EquusCell D
  • CanisCell StemWrap

Quantifiable outcome

  • Horses resumed activities in half the time compared to conventional treatments
  • +4 more outcomes

Companies that use AniCell Biotech

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

AniCell Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AniCell Biotech partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and minor.

  • MWI Animal HealthcoreChannel Partner/ Reseller/ DistributorMWI Animal Health is AniCell's primary distribution partner for veterinary products across the United States. The website displays 'Proud to be distributed by MWI' indicating a formal distribution agreement.
  • American Association of Equine Practitioners (AAEP)coreGTM or Marketing PartnerAniCell is a corporate sponsor of AAEP and presents at annual conferences. Hosts AAEP Conference Registration for CE courses. Company has presented at AAEP events for multiple years.
  • North American Veterinary Community (VMX Conference)majorGTM or Marketing PartnerExhibits at VMX Conference (Booth 2649) annually, showcasing products to veterinary professionals from around the world.
  • Western Veterinary Conference (WVC)majorGTM or Marketing PartnerExhibits at WVC Vegas Conference (Booth 3961) annually with presence in February.
  • Lake Tahoe Equine ConferencemajorGTM or Marketing PartnerParticipates in the Forty-Seventh Annual Lake Tahoe Equine Conference (January 26-30, 2026) as an exhibitor and educational supporter.
  • TEVA FoundationminorGTM or Marketing PartnerCorporate sponsor of Texas Equine Veterinary Association Foundation events and silent auctions supporting veterinarians in need.
  • ISELPminorGTM or Marketing PartnerCorporate sponsor of ISELP (International Society of Equine Professionals). Company logo appears alongside 'Proud to be corporate sponsors of ISELP'.
  • Dr. Marty GoldsteinminorStrategic or Co-development PartnerPartnership with Dr. Marty Goldstein DVM who lectures on integrative veterinary approaches to promote longevity and wellness through regenerative technologies. Company provides support for his educational presentations.
  • North Carolina State University - Schnabel LabcoreStrategic or Co-development PartnerDr. Lauren Schnabel at NC State University conducts clinical research on AniCell products including StemWrap wound healing studies. Her lab published peer-reviewed research supporting product efficacy.
  • Dr. Moises Barcelo (Dr. Moises Barcelo-Fimbres)coreStrategic or Co-development PartnerBioprocess engineer and research veterinarian Dr. Moises Barcelo has developed multiple product lines including EquusCell, CanisCell, and temperature-independent products. Key inventor and technical advisor.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

AniCell Biotech competitors and assessment

Company assessment

Broad incumbents

  • Vetoquinol: Vetoquinol is a global animal-health pharma with equine and companion animal therapeutics (including regenerative/orthopedic adjacencies); another broad incumbent that competes for shelf space and CE audiences at AAEP/VMX/WVC where AniCell also markets.
  • Heska (Mars Petcare): Heska, now part of Mars Petcare, sells in-clinic diagnostics and therapeutic products to companion-animal practices; overlaps in the same vet-channel buyer as AniCell and could potentially house or bundle regenerative SKUs at scale.
  • Zoetis: Zoetis is the largest global animal-health company with equine and companion animal portfolios including regenerative and biologic adjacencies (e.g., cytology, PRP, orthobiologics), serving as the dominant broad incumbent AniCell could be acquired by or compete against.
  • Dechra Pharmaceuticals: Dechra is a specialty animal-health pharma with strong equine (Equistro, orthopedic) and small-animal therapeutic lines; an active acquirer of niche regenerative/biologic franchises and a logical strategic acquirer of a platform like AniCell.
  • Elanco Animal Health: Elanco Animal Health is a major broad-line animal-health company with companion-animal and equine product portfolios, providing scale distribution and R&D resources against which AniCell's niche regenerative offerings must compete for clinic mind-share.
  • Boehringer Ingelheim Animal Health: Boehringer Ingelheim Animal Health is a top-tier global animal-health company with equine, livestock, and pet therapeutics; its broad regenerative/biologic R&D budget dwarfs AniCell's and frames the competitive ceiling in advanced veterinary therapeutics.

Direct peers

  • Ardent Animal Health: Ardent Animal Health (parent of MediVet Biologics) provides platelet-rich plasma and regenerative therapies for companion animals and horses, directly overlapping AniCell's regenerative product positioning in vet clinics.
  • VetStem Biopharma: VetStem Biopharma is a regenerative medicine company offering autologous stem cell therapy services for dogs and horses, the closest functional analogue to AniCell's amnion-derived allograft products and the typical alternative veterinarians compare against.
  • MediVet Biologics (Ardent): MediVet Biologics, now part of Ardent Animal Health, sells in-clinic regenerative kits (e.g., in-clinic stem cell kits) used by equine and small animal vets; comparable distribution motion (vet channel) and competitive substitute to AniCell's allograft approach.

Emerging players

  • PetVivo Holdings: PetVivo commercializes veterinary medical devices (e.g., Kushion and PrecisePRP) targeting osteoarthritis and tendon/ligament injuries in dogs and horses, competing in overlapping equine/canine regenerative and orthopedic indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

AniCell Biotech social profiles

Digital presence

AniCell Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AniCell Biotech leadership team

Management profile

Number of profiles

Profiles7 records

AniCell Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AniCell Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AniCell Biotech

What does AniCell Biotech do?

AniCell Biotech develops and manufactures ready-to-use, all-natural regenerative bioscaffold products derived from equine amniotic material for veterinary use. The portfolio includes two main brands—EquusCell for horses and CanisCell for dogs—with membrane bandages (StemWrap), injectable allografts (AniMatrX, AniMotion), ophthalmic products (AlloOcular, AniOcular), and temperature-independent formulations (AniCell D line). Products support wound management, tendon and ligament injuries, joint inflammation, and ocular conditions without requiring invasive stem cell harvesting.

Is AniCell Biotech a public or private company?

AniCell Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AniCell Biotech founded?

AniCell Biotech was founded in 2015. It employs 11 to 50 people.

Where is AniCell Biotech based?

AniCell Biotech is headquartered in Chandler, United States, in the North America region.

How does AniCell Biotech make money?

Two revenue lines are on record. Veterinary Product Sales are the primary driver. The others are distribution Partnership Revenue.

Who are AniCell Biotech's main competitors?

Broad incumbents on record are Vetoquinol, Heska (Mars Petcare), Zoetis, Dechra Pharmaceuticals, Elanco Animal Health and Boehringer Ingelheim Animal Health. Direct peers are Ardent Animal Health, VetStem Biopharma and MediVet Biologics (Ardent). PetVivo Holdings is listed as an emerging player.

Does AniCell Biotech have an API?

No public API is recorded for AniCell Biotech.

What industry is AniCell Biotech in?

AniCell Biotech's product category is Veterinary Regenerative Medicine. Its primary akta.pro industry code is HLAMANAK, Point-of-Care Regenerative Kits & Devices (Processing/Delivery), with a secondary code of HLAMANAG, Wound Healing & Dermatologic Regeneration. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals